SCHEMBL2411682

SCHEMBL2411682

CCOc1nc(N2CCCC2CO)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
ADK P55263 1/20 0.39
FPR2 P25090 1/20 0.38
SCN9A Q15858 1/20 0.38
CHUK O15111 2/20 0.38
CCNE1 P24864 3/20 0.38
CDK2 P24941 3/20 0.38
CDK1 P06493 2/20 0.38
CCNB1 P14635 2/20 0.38
ADORA2A P29274 5/20 0.38
ADORA1 P30542 5/20 0.38
ADORA3 P0DMS8 4/20 0.38
ALOX5AP P20292 1/20 0.37
ADORA2B P29275 1/20 0.36
SYK P43405 1/20 0.36
CCNE2 O96020 1/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2410711 0.88 ADK (0.41) PDE10AMKNK1MKNK2ADKFPR2
SCHEMBL2415080 0.88 ADORA2A (0.41) PDE10AMKNK1MKNK2ADKFPR2
SCHEMBL2415051 0.81 ALDH1A1 (0.45) ALOX5APSYK
SCHEMBL2410417 0.81 KCNJ5 (0.33) PDE10ACDK2
SCHEMBL2415235 0.80 ADK (0.43) PDE10AMKNK1MKNK2ADKFPR2
SCHEMBL27515787 0.80 FPR2 (0.37) PDE10AMKNK1MKNK2ADKFPR2
SCHEMBL2412675 0.79 CHUK (0.47) PDE10AADKFPR2SCN9ACHUK
SCHEMBL2417782 0.78 MAP4K4 (0.39) PDE10A
SCHEMBL2415018 0.78 CHUK (0.43) MKNK1MKNK2ADKFPR2SCN9A
SCHEMBL2413665 0.78 CHUK (0.39) PDE10AMKNK1MKNK2ADKFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN claimed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US claimed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US claimed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP disclosed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN disclosed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US disclosed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US disclosed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN disclosed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres KRT18, DPYD, DSP PDE10A 3263/4885MKNK1 2218/4885MKNK2 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.